Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01264393 · ClinicalTrials.gov registry record · Phase 3
State-wide Health Approach to Increase Reach and Effectiveness: Study 1
A Phase 3 study of Obesity, sponsored by The Miriam Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT01264393 is a Phase 3 study of Obesity that has completed, run by The Miriam Hospital. The registered enrollment target is 500 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01264393, a Phase 3 study of Obesity, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Behavioral weight loss programs can successfully reduce body weight, but these programs are available to limited numbers of overweight and obese individuals. This project evaluates a unique weight loss approach that combines a self-sustaining weight loss campaign (for outreach) with training in behavioral weight loss strategies and strategies to increase accountability (to improve weight loss success). This innovative combination has the potential to be a cost-effective model for disseminating weight control interventions.
Conditions Studied
Interventions
- BEHAVIORAL Shape Up Rhode Island + Online Resources
- BEHAVIORAL Shape Up Rhode Island + Online Weight Loss Program
- BEHAVIORAL Shape Up Rhode Island + Online Weight Loss Program + Group sessions
Study Locations (1)
Rhode Island
- The Miriam Hospital's Weight Control and Diabetes Research Center - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01264393
The ClinicalTrials.gov registry entry for NCT01264393 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower). The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Shape Up Rhode Island + Online Resources is the first listed.
NCT01264393 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01264393 about?
NCT01264393 is a clinical study titled "State-wide Health Approach to Increase Reach and Effectiveness: Study 1". Behavioral weight loss programs can successfully reduce body weight, but these programs are available to limited numbers of overweight and obese individuals. This project evaluates a unique weight loss approach that combines a self-sustaining weight loss campaign (for outreach) with training in beha...
What is the current status of trial NCT01264393?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 500 participants. The study started on 2011-01. Estimated completion is 2013-03.
What conditions does trial NCT01264393 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT01264393?
The interventions under investigation include: Shape Up Rhode Island + Online Resources (BEHAVIORAL), Shape Up Rhode Island + Online Weight Loss Program (BEHAVIORAL), Shape Up Rhode Island + Online Weight Loss Program + Group sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT01264393?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01264393 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RECRUITING · Phase 3
-
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
RECRUITING · Phase 3
-
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
RECRUITING · Phase 3
-
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RECRUITING · Phase 3
-
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.